Figure 3.
Effect of hypoxic-preconditioned mesenchymal stem cells (HP-MSCs) on microglia activation after hypoxic-ischemic (HI) injury in vivo and lipopolysaccharide (LPS) exposure in vitro. A, Perilesional locations of images taken in ionized calcium-binding adapter molecule 1 (IBA1)-stained brain sections at P28. B, Quantification of perimeter of IBA1+ cells. C, Quantification of Feret diameter of IBA1+ cells. D, Representative fluorescent images of perilesional IBA1+ cells (40×) in SHAM controls, HI-vehicle (VEH), HI–normoxic-preconditioned MSC (NP-MSC), and HI–HP-MSC mice. E, left, schematic overview of non-contact co-culture of primary-isolated mouse microglia exposed to 50 ng/mL LPS with NP-MSCs or HP-MSC (purple cells) in the hanging insert, green dots represent MSC secretome that can reach the medium of the microglia; right, TNF-α (tumor necrosis factor-α) secretion by microglia after 24-hour exposure to LPS. Data represent mean±SD. B and C, SHAM: n=17, HI-VEH: n=19, HI–NP-MSC: n=22, and HI–HP-MSC: n=21. E, n=5 per condition. DAPI indicates 4',6-diamidino-2-phenylindole. *P<0.05, **P<0.01, ***P<0.001 between indicated groups, ####P<0.0001 compared with non-LPS condition.
